XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

Xynomic Pharmaceuticals Holdings, Inc., a SPAC-related entity registered under CIK 0001697805, operates in the pharmaceutical and biopharmaceutical sector with a focus on oncology-stage drug development. The company filed an amended current report on Form 8-K/A with the SEC on July 5, 2019, with accession number 0001213900-19-012120, reflecting updates tied to activity surrounding its business combination process. The filing is consistent with the disclosure requirements that accompany SPAC transactions and post-combination restructuring typical of the 2018-2019 deal cycle. Sponsor details were not clearly disclosed in the available filing metadata. To access the full filing history, deal timeline, and sponsor data for Xynomic Pharmaceuticals Holdings and hundreds of other SPAC vehicles, sign up for a SpacDesk account at spacdesk.com.